| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 114.972 | 114.594 | 118.755 | 134.258 | 127.314 | 144.080 | 165.172 | 169.527 | 223.653 | 233.238 |
| Total Income - EUR | 114.975 | 114.600 | 118.766 | 134.260 | 127.318 | 144.085 | 165.176 | 169.736 | 223.682 | 233.706 |
| Total Expenses - EUR | 87.066 | 70.851 | 72.096 | 78.346 | 76.948 | 79.180 | 83.961 | 100.575 | 122.954 | 146.987 |
| Gross Profit/Loss - EUR | 27.908 | 43.749 | 46.670 | 55.914 | 50.370 | 64.905 | 81.215 | 69.162 | 100.728 | 86.719 |
| Net Profit/Loss - EUR | 23.391 | 36.750 | 45.541 | 54.571 | 49.097 | 63.464 | 79.564 | 67.498 | 98.536 | 79.848 |
| Employees | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 5 |
Check the financial reports for the company - Bioxpert Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 54.250 | 45.486 | 34.969 | 49.188 | 36.917 | 24.967 | 30.500 | 44.603 | 56.137 | 171.192 |
| Current Assets | 38.233 | 69.647 | 25.047 | 43.187 | 17.049 | 26.579 | 57.047 | 30.594 | 83.317 | 111.798 |
| Inventories | 663 | -43 | 0 | 0 | 0 | 0 | 852 | 0 | 0 | 0 |
| Receivables | 7.574 | 16.106 | 6.545 | 7.143 | 1.313 | 791 | 223 | 7.230 | 8.190 | 78.492 |
| Cash | 29.996 | 53.585 | 18.502 | 36.045 | 15.736 | 25.788 | 55.972 | 23.364 | 75.127 | 33.306 |
| Shareholders Funds | 92.483 | 101.754 | 56.771 | 65.595 | 10.810 | 41.815 | 79.616 | 67.551 | 98.588 | 79.901 |
| Social Capital | 0 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 0 | 13.379 | 3.245 | 26.780 | 43.156 | 9.731 | 7.930 | 7.646 | 41.491 | 203.089 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Bioxpert Srl